483 MicroBiopharm Japan Mar 2018

483 MicroBiopharm Japan Mar 2018

Jason Caballero FDA, Vioela Caze FDA$119.00 - Available Now

FDA investigators audited the MicroBiopharm Japan - Iwata, Japan facility and issued inspectional observations (via FDA 483) on 16 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Mar 2018
  • Location: Iwata, Japan
  • FEI: 3003992082
Add To Cart